Results 4,561-4,580 of 11,187 for speaker:Colm Burke

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 501. To ask the Minister for Health if he intends to launch a public consultation for industry and interested stakeholders to assist in developing Ireland’s position in relation to the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38283/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 503. To ask the Minister for Health his views on whether the European Union Pharmaceutical Strategy could place at risk certain intellectual property rights, including those for orphan and paediatric medicines; if such a move could damage jobs, competitiveness and the development of new medicines; and if he will make a statement on the matter. [38285/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 505. To ask the Minister for Health his views on whether there is a role for Ireland, along with other economically advanced, similar-sized countries in supporting the protection of innovation in the European Union Pharmaceutical Strategy in order that Ireland remains competitive for new investments and raise standards of care; and if he will make a statement on the matter. [38287/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 567. To ask the Minister for Health if he will outline the Government’s position on the European Union Pharmaceutical Strategy as the European Commission finalises its proposal for December 2022; and if he will make a statement on the matter. [38788/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 568. To ask the Minister for Health the last time the European Union Pharmaceutical Strategy was discussed at an EPSCO Meeting; if Ireland contributed to that discussion; and if he will make a statement on the matter. [38789/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 569. To ask the Minister for Health if he has engaged with the Department of An Taoiseach in relation to formulating a Government position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38790/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 570. To ask the Minister for Health if he has engaged with the Department of Enterprise, Trade and Employment in relation to formulating a position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38791/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 571. To ask the Minister for Health if he has engaged with the Department of Further and Higher Education, Research, Innovation and Science in relation to formulating a Government position on the European Union Pharmaceutical Strategy; and if he will make a statement on the matter. [38792/22]

Written Answers — Department of Health: Covid-19 Pandemic (13 Jul 2022)

Colm Burke: 478. To ask the Minister for Health if he will outline in detail the plans that his Department has to implement guidelines and structures to support general practitioners in assisting patients with long-Covid to ensure that they receive appropriate care; and if he will make a statement on the matter. [38259/22]

Written Answers — Department of Health: Covid-19 Pandemic (13 Jul 2022)

Colm Burke: 479. To ask the Minister for Health if he will outline in detail the way that his Department plans to ensure the Model of Care plan published in September 2021 is fully implemented in all chosen sites; if consideration will be given to updating the plan to reflect the emerging knowledge of the neurological nature of the condition; and if he will make a statement on the matter. [38260/22]

Written Answers — Department of Health: Intellectual Property (13 Jul 2022)

Colm Burke: 502. To ask the Minister for Health his views on whether medicines pricing and intellectual property rights are unrelated, with pricing determined by national governments through industry negotiations and intellectual property rights set through international trade agreements as incentives for innovation; and if he will make a statement on the matter. [38284/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 504. To ask the Minister for Health his views on whether a proposal by an organisation (details supplied) on equity-based tiered pricing would help to broaden access to new medicines for all Europe’s citizens; and if he will make a statement on the matter. [38286/22]

Written Answers — Department of Health: Medicinal Products (13 Jul 2022)

Colm Burke: 506. To ask the Minister for Health if he intends to increase his Department’s representation in Brussels to ensure Ireland’s position is adequately represented in European Council negotiations; and if he will make a statement on the matter. [38288/22]

Joint Oireachtas Committee on Health: Integrated Eye Care: Discussion (13 Jul 2022)

Colm Burke: I thank the witnesses for the presentation. I am on the board of the South Infirmary Victoria University Hospital. We have completed a new outpatient ophthalmology unit and two theatres are due to be finished by 1 October. My concern is that there is still a huge waiting list. A new unit ophthalmology unit has been built in Ballincollig which will employ 32 people. The problem is that it...

Joint Oireachtas Committee on Health: Integrated Eye Care: Discussion (13 Jul 2022)

Colm Burke: Is there ongoing consultation between all of the units across the country or is it only between certain units?

Joint Oireachtas Committee on Health: Integrated Eye Care: Discussion (13 Jul 2022)

Colm Burke: There are 19 maternity units in the country. There seems to be much more co-operation between them. Some units cannot do certain procedures and, therefore, there is a mechanism for referring patients. Do we need to do something similar with ophthalmology and develop far more co-operation? In each area of medicine, there is sub-specialisation. Is that the way to deal with this issue?

Joint Oireachtas Committee on Health: Integrated Eye Care: Discussion (13 Jul 2022)

Colm Burke: The funding for Ballincollig is from the HSE, not the South Infirmary Victoria University Hospital. The building has been completed, but we need funding for the equipment and to get it up and running. Also, obviously additional staff are required as well. With regard to fast-tracking the waiting lists that exist at present and a co-ordinated approach, and Professor Keegan says that is...

Joint Oireachtas Committee on Health: Integrated Eye Care: Discussion (13 Jul 2022)

Colm Burke: Has the IT system NERIECS wishes to use been identified at this stage?

Joint Oireachtas Committee on Health: Integrated Eye Care: Discussion (13 Jul 2022)

Colm Burke: Is there not a problem in Ireland in that we have 1,200 to 1,400 different systems between all the private hospitals, public hospitals and everything else? Denmark started back in 1996 and it is down to 12 or 14 systems and it is working down towards five systems. It has a huge saving as a result. Do we need to make sure now that we co-ordinate not only with IT but with the other sections...

Joint Oireachtas Committee on Health: Integrated Eye Care: Discussion (13 Jul 2022)

Colm Burke: We have done it in maternity services. Four units have a fully integrated IT system. I am not sure whether it has been expanded into the other areas yet.